Curran Simpson, Chief Executive Officer at REGENXBIO Inc. (RGNX), sold 41,622 shares at $12.62 ($525K) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($525k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.62 | 20,811 | $263K | 50.0% |
| 2 | $12.62 | 20,811 | $263K | 50.0% |
| Total | $12.62 avg | 41,622 | $525K | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.2M | — | Filing → |